Review



rabbit anti isg56  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Proteintech rabbit anti isg56
    Rabbit Anti Isg56, supplied by Proteintech, used in various techniques. Bioz Stars score: 86/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+isg56/pmc12935302-83-57-60?v=Proteintech
    Average 86 stars, based on 2 article reviews
    rabbit anti isg56 - by Bioz Stars, 2026-08
    86/100 stars

    Images



    Similar Products

    86
    Proteintech rabbit anti isg56
    Rabbit Anti Isg56, supplied by Proteintech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+isg56/pmc12935302-83-57-60?v=Proteintech
    Average 86 stars, based on 1 article reviews
    rabbit anti isg56 - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc isg56
    nCoV-L induced cancer cell death in vitro and suppressed tumor growth in viv o (A) Schematic structure of the stem-loop-structured nCoV-L RNA agonist. (B, C) nCoV-L activated the RIG-I signalling in cancer cells. Hep3B (B) or Huh7 (C) cells were collected and subjected to Western blot analysis after treated with Lipo or Lipo mixed with 2 μg nCoV-L for 24 h. Protein levels of RIG-I, p-IRF3, STAT1, p-STAT1, p–NF–κb and <t>ISG56</t> were compared to control and Lipo groups. (D) RIG-I signalling deficiency suppressed nCoV-L-induced cell death. Huh7.5.1 cells were transfected with 50 ng nCoV-L. Cell viability was measured 24 h post-transfection using a CCK-8 assay. Data represented mean ± SD; P < 0.05. (E) Ablation of 5ʹ-PPP abolishes nCoV-L-induced cell death. Hep3B cells were transfected with 200 ng of in vitro -transcribed nCoV-L RNA or 5ʹ-PPP-deficient synthetic nCoV-L RNA. Cell viability was quantified 24 h later by CCK-8 assay. Data represented mean ± SD; P < 0.0001. (F) Dose-dependent cytotoxicity of nCoV-L across carcinoma cell lines. Hep3B, NCI–H460, SW620, SW480, and CT26.WT cells were transfected with 50, 100, or 150 ng nCoV-L. Cell viability was assessed 48 h post-transfection using CCK-8 assay. (G) nCoV-L suppressed NCI–H1299 xenograft growth. Mice received intratumoral injections of PBS, lipo, or 10 μg nCoV-L complexed with lipo (nCoV-L/lipo) for 5 consecutive days (arrows, days 0–4). Tumor volumes are shown as mean ± SEM (n = 5); P < 0.0001 vs. PBS (two-way ANOVA). (H) Representative excised tumors from (G). Scale bar: 0.5 cm.
    Isg56, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+isg56/pmc12803795-32-16-24?v=Cell+Signaling+Technology+Inc
    Average 95 stars, based on 1 article reviews
    isg56 - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    93
    Proteintech anti isg56 rabbit pab
    nCoV-L induced cancer cell death in vitro and suppressed tumor growth in viv o (A) Schematic structure of the stem-loop-structured nCoV-L RNA agonist. (B, C) nCoV-L activated the RIG-I signalling in cancer cells. Hep3B (B) or Huh7 (C) cells were collected and subjected to Western blot analysis after treated with Lipo or Lipo mixed with 2 μg nCoV-L for 24 h. Protein levels of RIG-I, p-IRF3, STAT1, p-STAT1, p–NF–κb and <t>ISG56</t> were compared to control and Lipo groups. (D) RIG-I signalling deficiency suppressed nCoV-L-induced cell death. Huh7.5.1 cells were transfected with 50 ng nCoV-L. Cell viability was measured 24 h post-transfection using a CCK-8 assay. Data represented mean ± SD; P < 0.05. (E) Ablation of 5ʹ-PPP abolishes nCoV-L-induced cell death. Hep3B cells were transfected with 200 ng of in vitro -transcribed nCoV-L RNA or 5ʹ-PPP-deficient synthetic nCoV-L RNA. Cell viability was quantified 24 h later by CCK-8 assay. Data represented mean ± SD; P < 0.0001. (F) Dose-dependent cytotoxicity of nCoV-L across carcinoma cell lines. Hep3B, NCI–H460, SW620, SW480, and CT26.WT cells were transfected with 50, 100, or 150 ng nCoV-L. Cell viability was assessed 48 h post-transfection using CCK-8 assay. (G) nCoV-L suppressed NCI–H1299 xenograft growth. Mice received intratumoral injections of PBS, lipo, or 10 μg nCoV-L complexed with lipo (nCoV-L/lipo) for 5 consecutive days (arrows, days 0–4). Tumor volumes are shown as mean ± SEM (n = 5); P < 0.0001 vs. PBS (two-way ANOVA). (H) Representative excised tumors from (G). Scale bar: 0.5 cm.
    Anti Isg56 Rabbit Pab, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+isg56/pm40006954-48-6-44?v=Proteintech
    Average 93 stars, based on 1 article reviews
    anti isg56 rabbit pab - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    90
    GeneTex rabbit anti-isg56
    nCoV-L induced cancer cell death in vitro and suppressed tumor growth in viv o (A) Schematic structure of the stem-loop-structured nCoV-L RNA agonist. (B, C) nCoV-L activated the RIG-I signalling in cancer cells. Hep3B (B) or Huh7 (C) cells were collected and subjected to Western blot analysis after treated with Lipo or Lipo mixed with 2 μg nCoV-L for 24 h. Protein levels of RIG-I, p-IRF3, STAT1, p-STAT1, p–NF–κb and <t>ISG56</t> were compared to control and Lipo groups. (D) RIG-I signalling deficiency suppressed nCoV-L-induced cell death. Huh7.5.1 cells were transfected with 50 ng nCoV-L. Cell viability was measured 24 h post-transfection using a CCK-8 assay. Data represented mean ± SD; P < 0.05. (E) Ablation of 5ʹ-PPP abolishes nCoV-L-induced cell death. Hep3B cells were transfected with 200 ng of in vitro -transcribed nCoV-L RNA or 5ʹ-PPP-deficient synthetic nCoV-L RNA. Cell viability was quantified 24 h later by CCK-8 assay. Data represented mean ± SD; P < 0.0001. (F) Dose-dependent cytotoxicity of nCoV-L across carcinoma cell lines. Hep3B, NCI–H460, SW620, SW480, and CT26.WT cells were transfected with 50, 100, or 150 ng nCoV-L. Cell viability was assessed 48 h post-transfection using CCK-8 assay. (G) nCoV-L suppressed NCI–H1299 xenograft growth. Mice received intratumoral injections of PBS, lipo, or 10 μg nCoV-L complexed with lipo (nCoV-L/lipo) for 5 consecutive days (arrows, days 0–4). Tumor volumes are shown as mean ± SEM (n = 5); P < 0.0001 vs. PBS (two-way ANOVA). (H) Representative excised tumors from (G). Scale bar: 0.5 cm.
    Rabbit Anti Isg56, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+isg56/pm38923445-79-18-25?v=GeneTex
    Average 90 stars, based on 1 article reviews
    rabbit anti-isg56 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    GeneTex rabbit anti-isg56/ifit1 polyclonal antibody gtx31570
    nCoV-L induced cancer cell death in vitro and suppressed tumor growth in viv o (A) Schematic structure of the stem-loop-structured nCoV-L RNA agonist. (B, C) nCoV-L activated the RIG-I signalling in cancer cells. Hep3B (B) or Huh7 (C) cells were collected and subjected to Western blot analysis after treated with Lipo or Lipo mixed with 2 μg nCoV-L for 24 h. Protein levels of RIG-I, p-IRF3, STAT1, p-STAT1, p–NF–κb and <t>ISG56</t> were compared to control and Lipo groups. (D) RIG-I signalling deficiency suppressed nCoV-L-induced cell death. Huh7.5.1 cells were transfected with 50 ng nCoV-L. Cell viability was measured 24 h post-transfection using a CCK-8 assay. Data represented mean ± SD; P < 0.05. (E) Ablation of 5ʹ-PPP abolishes nCoV-L-induced cell death. Hep3B cells were transfected with 200 ng of in vitro -transcribed nCoV-L RNA or 5ʹ-PPP-deficient synthetic nCoV-L RNA. Cell viability was quantified 24 h later by CCK-8 assay. Data represented mean ± SD; P < 0.0001. (F) Dose-dependent cytotoxicity of nCoV-L across carcinoma cell lines. Hep3B, NCI–H460, SW620, SW480, and CT26.WT cells were transfected with 50, 100, or 150 ng nCoV-L. Cell viability was assessed 48 h post-transfection using CCK-8 assay. (G) nCoV-L suppressed NCI–H1299 xenograft growth. Mice received intratumoral injections of PBS, lipo, or 10 μg nCoV-L complexed with lipo (nCoV-L/lipo) for 5 consecutive days (arrows, days 0–4). Tumor volumes are shown as mean ± SEM (n = 5); P < 0.0001 vs. PBS (two-way ANOVA). (H) Representative excised tumors from (G). Scale bar: 0.5 cm.
    Rabbit Anti Isg56/Ifit1 Polyclonal Antibody Gtx31570, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+isg56/pmc11176439-80-4-10?v=GeneTex
    Average 90 stars, based on 1 article reviews
    rabbit anti-isg56/ifit1 polyclonal antibody gtx31570 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    93
    Proteintech rabbit anti ifit1 isg56 pab
    nCoV-L induced cancer cell death in vitro and suppressed tumor growth in viv o (A) Schematic structure of the stem-loop-structured nCoV-L RNA agonist. (B, C) nCoV-L activated the RIG-I signalling in cancer cells. Hep3B (B) or Huh7 (C) cells were collected and subjected to Western blot analysis after treated with Lipo or Lipo mixed with 2 μg nCoV-L for 24 h. Protein levels of RIG-I, p-IRF3, STAT1, p-STAT1, p–NF–κb and <t>ISG56</t> were compared to control and Lipo groups. (D) RIG-I signalling deficiency suppressed nCoV-L-induced cell death. Huh7.5.1 cells were transfected with 50 ng nCoV-L. Cell viability was measured 24 h post-transfection using a CCK-8 assay. Data represented mean ± SD; P < 0.05. (E) Ablation of 5ʹ-PPP abolishes nCoV-L-induced cell death. Hep3B cells were transfected with 200 ng of in vitro -transcribed nCoV-L RNA or 5ʹ-PPP-deficient synthetic nCoV-L RNA. Cell viability was quantified 24 h later by CCK-8 assay. Data represented mean ± SD; P < 0.0001. (F) Dose-dependent cytotoxicity of nCoV-L across carcinoma cell lines. Hep3B, NCI–H460, SW620, SW480, and CT26.WT cells were transfected with 50, 100, or 150 ng nCoV-L. Cell viability was assessed 48 h post-transfection using CCK-8 assay. (G) nCoV-L suppressed NCI–H1299 xenograft growth. Mice received intratumoral injections of PBS, lipo, or 10 μg nCoV-L complexed with lipo (nCoV-L/lipo) for 5 consecutive days (arrows, days 0–4). Tumor volumes are shown as mean ± SEM (n = 5); P < 0.0001 vs. PBS (two-way ANOVA). (H) Representative excised tumors from (G). Scale bar: 0.5 cm.
    Rabbit Anti Ifit1 Isg56 Pab, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+isg56/pm38331257-130-27-37?v=Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti ifit1 isg56 pab - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc anti isg56
    nCoV-L induced cancer cell death in vitro and suppressed tumor growth in viv o (A) Schematic structure of the stem-loop-structured nCoV-L RNA agonist. (B, C) nCoV-L activated the RIG-I signalling in cancer cells. Hep3B (B) or Huh7 (C) cells were collected and subjected to Western blot analysis after treated with Lipo or Lipo mixed with 2 μg nCoV-L for 24 h. Protein levels of RIG-I, p-IRF3, STAT1, p-STAT1, p–NF–κb and <t>ISG56</t> were compared to control and Lipo groups. (D) RIG-I signalling deficiency suppressed nCoV-L-induced cell death. Huh7.5.1 cells were transfected with 50 ng nCoV-L. Cell viability was measured 24 h post-transfection using a CCK-8 assay. Data represented mean ± SD; P < 0.05. (E) Ablation of 5ʹ-PPP abolishes nCoV-L-induced cell death. Hep3B cells were transfected with 200 ng of in vitro -transcribed nCoV-L RNA or 5ʹ-PPP-deficient synthetic nCoV-L RNA. Cell viability was quantified 24 h later by CCK-8 assay. Data represented mean ± SD; P < 0.0001. (F) Dose-dependent cytotoxicity of nCoV-L across carcinoma cell lines. Hep3B, NCI–H460, SW620, SW480, and CT26.WT cells were transfected with 50, 100, or 150 ng nCoV-L. Cell viability was assessed 48 h post-transfection using CCK-8 assay. (G) nCoV-L suppressed NCI–H1299 xenograft growth. Mice received intratumoral injections of PBS, lipo, or 10 μg nCoV-L complexed with lipo (nCoV-L/lipo) for 5 consecutive days (arrows, days 0–4). Tumor volumes are shown as mean ± SEM (n = 5); P < 0.0001 vs. PBS (two-way ANOVA). (H) Representative excised tumors from (G). Scale bar: 0.5 cm.
    Anti Isg56, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+isg56/pm37219433-123-10-14?v=Cell+Signaling+Technology+Inc
    Average 95 stars, based on 1 article reviews
    anti isg56 - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    Image Search Results


    nCoV-L induced cancer cell death in vitro and suppressed tumor growth in viv o (A) Schematic structure of the stem-loop-structured nCoV-L RNA agonist. (B, C) nCoV-L activated the RIG-I signalling in cancer cells. Hep3B (B) or Huh7 (C) cells were collected and subjected to Western blot analysis after treated with Lipo or Lipo mixed with 2 μg nCoV-L for 24 h. Protein levels of RIG-I, p-IRF3, STAT1, p-STAT1, p–NF–κb and ISG56 were compared to control and Lipo groups. (D) RIG-I signalling deficiency suppressed nCoV-L-induced cell death. Huh7.5.1 cells were transfected with 50 ng nCoV-L. Cell viability was measured 24 h post-transfection using a CCK-8 assay. Data represented mean ± SD; P < 0.05. (E) Ablation of 5ʹ-PPP abolishes nCoV-L-induced cell death. Hep3B cells were transfected with 200 ng of in vitro -transcribed nCoV-L RNA or 5ʹ-PPP-deficient synthetic nCoV-L RNA. Cell viability was quantified 24 h later by CCK-8 assay. Data represented mean ± SD; P < 0.0001. (F) Dose-dependent cytotoxicity of nCoV-L across carcinoma cell lines. Hep3B, NCI–H460, SW620, SW480, and CT26.WT cells were transfected with 50, 100, or 150 ng nCoV-L. Cell viability was assessed 48 h post-transfection using CCK-8 assay. (G) nCoV-L suppressed NCI–H1299 xenograft growth. Mice received intratumoral injections of PBS, lipo, or 10 μg nCoV-L complexed with lipo (nCoV-L/lipo) for 5 consecutive days (arrows, days 0–4). Tumor volumes are shown as mean ± SEM (n = 5); P < 0.0001 vs. PBS (two-way ANOVA). (H) Representative excised tumors from (G). Scale bar: 0.5 cm.

    Journal: Biochemistry and Biophysics Reports

    Article Title: Anti-tumor analysis of the RIG-I agonist in vitro and in vivo

    doi: 10.1016/j.bbrep.2025.102249

    Figure Lengend Snippet: nCoV-L induced cancer cell death in vitro and suppressed tumor growth in viv o (A) Schematic structure of the stem-loop-structured nCoV-L RNA agonist. (B, C) nCoV-L activated the RIG-I signalling in cancer cells. Hep3B (B) or Huh7 (C) cells were collected and subjected to Western blot analysis after treated with Lipo or Lipo mixed with 2 μg nCoV-L for 24 h. Protein levels of RIG-I, p-IRF3, STAT1, p-STAT1, p–NF–κb and ISG56 were compared to control and Lipo groups. (D) RIG-I signalling deficiency suppressed nCoV-L-induced cell death. Huh7.5.1 cells were transfected with 50 ng nCoV-L. Cell viability was measured 24 h post-transfection using a CCK-8 assay. Data represented mean ± SD; P < 0.05. (E) Ablation of 5ʹ-PPP abolishes nCoV-L-induced cell death. Hep3B cells were transfected with 200 ng of in vitro -transcribed nCoV-L RNA or 5ʹ-PPP-deficient synthetic nCoV-L RNA. Cell viability was quantified 24 h later by CCK-8 assay. Data represented mean ± SD; P < 0.0001. (F) Dose-dependent cytotoxicity of nCoV-L across carcinoma cell lines. Hep3B, NCI–H460, SW620, SW480, and CT26.WT cells were transfected with 50, 100, or 150 ng nCoV-L. Cell viability was assessed 48 h post-transfection using CCK-8 assay. (G) nCoV-L suppressed NCI–H1299 xenograft growth. Mice received intratumoral injections of PBS, lipo, or 10 μg nCoV-L complexed with lipo (nCoV-L/lipo) for 5 consecutive days (arrows, days 0–4). Tumor volumes are shown as mean ± SEM (n = 5); P < 0.0001 vs. PBS (two-way ANOVA). (H) Representative excised tumors from (G). Scale bar: 0.5 cm.

    Article Snippet: Antibodies against cleaved-PARP (cat#5625S), cleaved-Caspase3 (cat#9661S), PUMA (cat#98672), p-IRF3 (cat#29047), STAT1 (cat#14994), p-STAT1 (cat#9167), p–NF–κb (cat#3033), ISG56 (cat#14769) and β-actin (cat#4967) were purchased from Cell Signaling Technology.

    Techniques: In Vitro, Western Blot, Control, Transfection, CCK-8 Assay